Profound Medical (PROF) Non-Current Deferred Tax Liability (2023 - 2024)
Profound Medical's quarterly Non-Current Deferred Tax Liability came in at $59000.0 in Q3 2024, up 2850.0% quarter-over-quarter from $2000.0 in Q2 2024.
Profound Medical has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $59000.0 in Q3 2024.
- For the quarter ending Q3 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $59000.0; the trailing twelve-month figure through Sep 2024 stood at $59000.0 (changed N/A YoY), and the FY2023 full-year result was $59000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q3 2024 stood at $59000.0, up from $2000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $59000.0 in Q4 2023, with the low at $2000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 59,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |